Endpoints in studies on myocardial infarction-Reference-Cited by-同舟云学术

Endpoints in studies on myocardial infarction

Published:2007-04 Issue:9571 Volume:369 Page:1430
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Lapostolle F,Catineau J,Lapandry C,Adnet F

Publisher

Elsevier BV

Subject

General Medicine

Reference5 articles.

1. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2;Lancet,1988

2. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction;N Engl J Med,1993

3. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction;Andersen;N Engl J Med,2003

4. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial;Lancet,2006

5. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation;Sabatine;N Engl J Med,2005

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis and Prognosis of Objective Type II Myocardial Infarction;The American Journal of Medicine;2024-01

2. The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid and diabetes trials;European Heart Journal - Cardiovascular Pharmacotherapy;2019-08-29

3. Ethics in clinical research;Journal of Hepatology;2009-10

4. Insight into recent reforms and initiatives in Austria: implications for key stakeholders;Expert Review of Pharmacoeconomics & Outcomes Research;2008-08

5. Do we learn the right things from clinical trials?;European Journal of Clinical Pharmacology;2008-01-29